Table 1.
Physical characteristics, duration of hemodialysis, and metabolic parameters of participants.
| Parameter | n = 11 |
|---|---|
| Age (years) | 74.0 ± 5.2 |
| Male/female (n) | 7/4 |
| Duration of HD (months) | 32.9 ± 20.0 |
| BMI (kg/m²) | 22.7 ± 3.9 |
| SMI (kg/m²) | 6.9 ± 0.9/5.5 ± 0.3 |
| Glycoalbumin (%) | 18.7 ± 1.7 |
| HDL-cholesterol (mg/dL) | 10.2 ± 2.0 |
| LDL-cholesterol (mg/dL) | 15.4 ± 4.9 |
| Triglyceride (mg/dL) | 13.2 ± 4.8 |
| GNRI | 92.0 ± 4.2 |
| Sarcopenia (n) | 10 |
| Medication | |
| Insulin injection (n) | 3 |
| GLP-1 receptor agonist (n) | 2 |
| DPP-4 inhibitor (n) | 4 |
| α-GI (n) | 4 |
Values represent the mean ± standard deviation of the 11 participants. Abbreviations: α-GI, α-glucosidase inhibitor; BMI, body mass index; DPP-4 inhibitor, dipeptidyl peptidase IV inhibitor; GLP-1 receptor agonist, glucagon-like peptide receptor agonist; GNRI, Geriatric Nutritional Risk Index; HD, hemodialysis; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SMI, skeletal muscle index.